Related Experiment Video
Updated: Jul 14, 2026
10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Structural and biochemical characterization of inhibitor-1alpha
Hsien-Bin Huang1, Yi-Chen Chen, Ting-Ting Lee
1Institute of Molecular Biology, National Chung Cheng University, Chia-Yi 621, Taiwan, Republic of China.
Proteins
|May 19, 2007
Summary
Inhibitor-1alpha, a variant of human protein phosphatase inhibitor-1, retains similar structure and potent protein phosphatase-1 (PP1) inhibitory activity. This isoform is functionally comparable to inhibitor-1, despite lacking internal amino acids.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Protein phosphatase inhibitor-1 (I-1) is a key regulator of protein phosphatases.
- Inhibitor-1alpha is an alternatively spliced isoform of I-1, differing by the absence of 51 internal amino acids.
- Understanding the structural and functional impact of this deletion is crucial for comprehending phosphatase regulation.
Purpose of the Study:
- To characterize the structural and biochemical properties of inhibitor-1alpha.
- To compare the protein phosphatase-1 (PP1) inhibitory activity of inhibitor-1alpha with that of inhibitor-1.
- To assess the functional specificities of inhibitor-1alpha regarding phosphorylation and dephosphorylation.
Main Methods:
- Recombinant inhibitor-1alpha was produced and analyzed using Nuclear Magnetic Resonance (NMR) spectroscopy for structural determination.
- Inhibition assays were performed to determine the IC(50) values for PP1 inhibition.
- Kinetic parameters for phosphorylation by Protein Kinase A (PKA) and dephosphorylation by protein phosphatases-1, -2A, and -2B were measured.
Main Results:
- NMR analysis revealed that inhibitor-1alpha adopts a predominantly random coil conformation but shares structural features with inhibitor-1, excluding the deleted region.
- Inhibitor-1alpha demonstrated comparable IC(50) values to inhibitor-1 in inhibiting PP1, particularly when Thr-35 is phosphorylated by PKA.
- Kinetic parameters for PKA phosphorylation and subsequent dephosphorylation by various protein phosphatases were similar for both inhibitor-1alpha and inhibitor-1.
Conclusions:
- Inhibitor-1alpha preserves the overall structure of inhibitor-1.
- The PP1 inhibitory activity of inhibitor-1alpha is comparable to that of inhibitor-1.
- Inhibitor-1alpha maintains functional specificities for phosphorylation by PKA and dephosphorylation by protein phosphatases-1, -2A, and -2B.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!